USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

USD10
ORIC Shares
About ORIC PharmaceuticalsORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Stats

TRADING WINDOW

Closed

OPENS AT

Jun 9 at 1:30 PM GMT+0

MARKET CAP

$753.79M

OPEN PRICE

Not enough data

LOW (1Y)

$3.90

HIGH (1Y)

$14.93

LOW (24H)

$7.36

HIGH (24H)

$7.96

VOLUME (24H)

$1.01M

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$7.51
3.06%
1 Week
$8.03
3.61%
1 Month
$8.75
11.54%
1 Year
$9.75
20.62%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.